![]() RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | ![]() Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. | ![]() BioAtla BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer. | ||
Founding Date | Founding Date 2009 | Founding Date 2015 | Founding Date 2015 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Jupiter, US HQ | Locations South San Francisco, US HQ | Locations Waltham, US HQ | Locations San Diego, US HQ |
Employees | Employees 5 | Employees 64 | Employees 69 | Employees 616% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 69.8 m | Valuation ($) 43.5 m | Valuation ($) 100.8 m |
Financial | ||||
Net income | Net income N/A | Net income ($129.9m) (FY, 2024) | Net income ($35m) (FY, 2025) | Net income ($59.6m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 176m | Total funding raised $ 233m | Total funding raised $ 186.5m |

RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company
Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
View company
BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.
View company